Intrinsic Value of S&P & Nasdaq Contact Us

Hepion Pharmaceuticals, Inc. HEPA OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
58/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$70.00
+145733.3%

Stock Statistics — HEPA

Hepion Pharmaceuticals, Inc. (HEPA) has a market capitalization of $557.78K and trades at $0.05. The 52-week range is 0.033-0.746.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-0.88.

The stock has a beta of 1.61, operates in the Healthcare sector.

Trading Data
Current Price$0.05
52-Week Range0.033-0.746
Volume6
Avg Volume (30D)12.48K
Market Cap$557.78K
Beta (1Y)1.61
Company
IPO Date2014-02-10
Employees22
CEOVincent LoPriore
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS4268974015
CUSIP426897401
Income (Latest Year)
EBITDA$-8.25M
Operating Income$-4.16M
Net Income$-8.28M
EPS$-0.88
EPS Diluted$-0.88
Shares Outstanding$9.41M
Balance Sheet (Latest Year)
Total Assets$3.07M
Current Assets$3.07M
Cash & ST Investments$1.83M
Total Liabilities$402.41K
Total Debt$54.07K
Net Debt$-1.77M
Total Equity$2.67M
Debt / Equity0.02
Valuation Ratios
P/E Ratio-0.1
P/B Ratio0.21
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message